Skip to main content

Coronary Heart Disease and HRT (HERS Trial)-1998

  • Chapter
  • First Online:
Top Articles in Primary Care
  • 198 Accesses

Abstract

In the late 1980s and early 1990s, numerous observational studies noted lower rates of coronary heart disease (CHD) in women taking postmenopausal estrogen compared to women not taking postmenopausal hormone therapy. This association was noted to be strongest in women with established CHD. The Heart and Estrogen/progestin Replacement Study (HERS) Research Group attempted to answer whether there was a causal relationship between postmenopausal hormone therapy and risk of CHD.

Hulley, S., Grady, D., & Bush, T. (1998). Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women. JAMA, 280(7), 605–613. doi: 10.1001/jama.280.7.605.

Hyperlink to PDF: https://jamanetwork.com/journals/jama/fullarticle/187879.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initiative randomized controlled trial. JAMA. 2004;291(14):1701–12.

    Article  CAS  PubMed  Google Scholar 

  2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

    Article  CAS  PubMed  Google Scholar 

  3. US Preventive Services Task Force. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US preventive services task force recommendation statement. JAMA. 2017;318(22):2224–33. https://doi.org/10.1001/jama.2017.18261.

    Article  Google Scholar 

  4. Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol. 2012;120(3):595–603. https://doi.org/10.1097/AOG.0b013e318265df42. PMID: 22914469; PMCID: PMC3607288.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathleen E. Leary .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Leary, K.E. (2023). Coronary Heart Disease and HRT (HERS Trial)-1998. In: Russell, J., Skolnik, N.S. (eds) Top Articles in Primary Care. Springer, Cham. https://doi.org/10.1007/978-3-031-25620-2_73

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-25620-2_73

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-25619-6

  • Online ISBN: 978-3-031-25620-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics